Dattaraj Rao on LinkedIn: "Need a good metric for effectiveness of #artificialintelligence? Try 70% reduction in human time with improved quality. Amazing story Persistent Systems."

A 70% ROI! That's what LungLife AI, a pioneer in LiquidBiopsy technology, has achieved using machine learning and artificial intelligence to enable life-saving early diagnosis of lung cancer. Sara Barrington and Paul Pagano explain how Persistent #ML and #AI #algorithms have reduced analysis time by almost 70%, accelerating LungLife's efforts to greatly reduce the impact of disease that claims around 400 lives per day.